e-learning
resources
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid, Leonardo M. Fabbri
Source:
ERJ Open Res, 5 (1) 00185-2018; 10.1183/23120541.00185-2018
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid, Leonardo M. Fabbri. Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box. ERJ Open Res, 5 (1) 00185-2018; 10.1183/23120541.00185-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
New inhaler devices: the good, the bad, and the ugly
Clinically appropriate testing of different valved holding chamber (VHC)-facemask combinations investigating simulated delivered mass to carina
Related content which might interest you:
Triple therapy in COPD: Oportunities and challenges
Source: Short Video Statement 2020
Year: 2020
Triple therapy in COPD: only for the right patient
Source: Eur Respir J, 53 (4) 1900394; 10.1183/13993003.00394-2019
Year: 2019
LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Indacaterol/glycopyrronium (IND/GLY) delays clinically important deterioration (CID) versus salmeterol/fluticasone (SFC) in symptomatic COPD patients: LANTERN/ILLUMINATE pooled analysis
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Patient selection? One fits all (monotherapy versus combined therapy)?
Source: Sleep and Breathing Conference 2021
Year: 2021
Treatment of idiopathic pulmonary fibrosis (IPF) with nintedanib: an experience from the compassionate use program (CUP) in Estonia
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Is pulmonary rehabilitation (PR) an effective therapy in lymphangioleiomyomatosis (LAM)?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
The importance of the aplication long-therm therapy (LTOT) in COPD tretmant
Source: Eur Respir J 2006; 28: Suppl. 50, 519s
Year: 2006
Triple therapy trials in COPD: a precision medicine opportunity
Source: Eur Respir J, 52 (6) 1801848; 10.1183/13993003.01848-2018
Year: 2018
Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014
Indacaterol/glycopyrronium (IND/GLY) reduces the risk of clinically important deterioration (CID) versus open-label tiotropium (Tio) in COPD patients: Post hoc analysis from SHINE and SPARK studies
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
COPD: Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination and oxygen saturation (OS) in patients (pts) with different plasma surfactant protein D (SP-D) level
Source: International Congress 2015 – COPD: notable points
Year: 2015
Tobacco smoking (TS) in home oxygen therapy (HOT). Preliminary data (*)
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Bronchodilator combinations for COPD: real hopes or a new Pandora’s box?
Source: Eur Respir J 2013; 42: 1441-1445
Year: 2013
Is occupational therapy (OT) really needed in pulmonary rehabilitation programmes (PRP)?
Source: Eur Respir J 2005; 26: Suppl. 49, 529s
Year: 2005
LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results)
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Exacerbation frequency and eosinophil levels for GOLD C and D COPD patients currently prescribed multiple inhaler triple therapy (MITT)
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018
Beneficial effect of the LAMA/LABA glycopyrronium (GP)/formoterol (FF) fixed-dose combination, delivered using a novel MDI co-suspension technology (GFF MDI), in COPD GOLD group A and B patients
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
A randomised controlled trial of cognitive behavioural therapy (CBT) delivered by respiratory nurses to reduce anxiety in chronic obstructive pulmonary disease (COPD). (Trial registration - ISCRCTN55206395)
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept